RE: Company future29 Apr 2022 14:31
Applebee, I think you are not correct and your sentence is misleading.
What they are saying is many requirements to the funding terms, and delisting is a another proposal that we discussed here last week.
The main requirement ti funding is reduce cost, which they have already started.
Below is the Chairman's comments.
"I am grateful to the Noteholders for their continued support in providing this financing, despite the difficulties the business has faced over the past few months. This financing provides both the certainty of a future for Sensyne as an independent life sciences focused business and the opportunity to conclude the ongoing FSP. We will of necessity need to reduce our cost base and propose changes at a future general meeting that will have a significant impact on our shareholders' interests."